| Name | Title | Contact Details |
|---|
The BIG3 is the premier league for 3v3 hoops. Featuring many of the worlds most popular and accomplished athletes.
In 1954, in a one-room machine shop in Augusta, Georgia, the first Textron Specialized Vehicles products were born. Two brothers started with a simple belief that they could build a better golf car, that better met the customers needs, than any other vehicle on the market. Since those beginnings, the Textron Specialized Vehicles product line includes not only golf cars, but also ground support equipment for the aviation industry, industrial utility vehicles, and recreational side-by-side UTVs. The company has become a world leader in transportation and a leading global manufacturer of golf cars, side-by-sides, utility vehicles, personal transportation vehicles and aviation ground support equipment. We build thousands of vehicles each year, many of which featuring game-changing technology and innovations to improve vehicle efficiency and enhance the user experience like no other vehicle can. Today, Textron Specialized Vehicles includes brands that are leaders in the respective industries they serve -- Cushman®, E-Z-GO®, Arctic Cat®, Jacobsen®, Ransomes®, TUG™, Douglas™, Premier™, and Safeaero™. Since 1960, the company has been part of Textron Inc. (NYSE: TXT), a global multi-industry company headquartered in Providence, RI. A Fortune 500 company with more than 35,000 employees worldwide and operations in 25 countries, Textron is known for its powerful brands, including E-Z-GO, Cessna, Beechcraft, Hawker, Bell, and Kautex, among others. But nearly 70 years after our first product was built in that one-room shop, there is still that single belief – that we exist to build vehicles and services that exceed customers expectations, better than any other offering on the market. It is the drive to sustain and improve that position – to offer an unparalleled combination of world-class products, advanced technology, manufacturing expertise, and extraordinary service – that leads Textron Specialized Vehicles to cover new ground.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
RevGen GENIUS stands as a premier source for aiding businesses in crafting a robust and efficient go-to-market (GTM) strategy. With our expert guidance, clients can drive revenue growth with confidence.